The estimated Net Worth of Linda Maxwell is at least $692 Thousand dollars as of 27 May 2022. Linda Maxwell owns over 2,000 units of United Therapeutics Corp stock worth over $692,380 and over the last 4 years he sold UTHR stock worth over $0. In addition, he makes $0 as Director at United Therapeutics Corp.
Linda has made over 1 trades of the United Therapeutics Corp stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 2,000 units of UTHR stock worth $204,880 on 27 May 2022.
The largest trade he's ever made was exercising 2,000 units of United Therapeutics Corp stock on 27 May 2022 worth over $204,880. On average, Linda trades about 333 units every 0 days since 2020. As of 27 May 2022 he still owns at least 2,000 units of United Therapeutics Corp stock.
You can see the complete history of Linda Maxwell stock trades at the bottom of the page.
Dr. Linda Maxwell M.D. serves as Director of the Company. Dr. Maxwell is Adjunct Professor of Surgery at the University of Toronto, Distinguished Visiting Professor at Ryerson University, and Associate Scientist at the Li Ka Shing Knowledge Institute in Toronto. She served as Founding and Executive Director of the Biomedical Zone in 2015 – Canada’s first and only hospital-embedded, physician-led business incubator for emerging health technology companies – and has guided a wide variety of startup companies through clinical development, capitalization, and commercialization. Dr. Maxwell also managed a life sciences tech transfer. Dr. Maxwell earned an A.B. with honors from Harvard University, an M.D. from Yale University, and an M.B.A. from the University of Oxford. She serves as an independent member of the Board of Directors of Profound Medical Inc., a publicly-traded company listed both in the United States and Canada.
Linda's mailing address filed with the SEC is C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING, MD, 20910.
Over the last 20 years, insiders at United Therapeutics Corp have traded over $68,910,395 worth of United Therapeutics Corp stock and bought 229,703 units worth $13,655,671 . The most active insiders traders include Martine A Rothblatt, David Zaccardelli, and Roger Jeffs. On average, United Therapeutics Corp executives and independent directors trade stock every 3 days with the average trade being worth of $2,310,818. The most recent stock trade was executed by James Edgemond on 9 September 2024, trading 8,332 units of UTHR stock currently worth $991,341.
united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians
United Therapeutics Corp executives and other stock owners filed with the SEC include: